THIS IS A DIAGNOSTIC RADIO PHARMACEUTICAL CONTAINING IOFLUPANE-123. IT ALSO CONTAINS ACETIC ACID, SODIUM ACETATE, ETHANOL AND WATER. IT IS INJECTED INTO A PATIENT AND CARRIED BY THE BLOODSTREAM WHERE IT COLLECTS IN A SMALL AREA OF THE BRAIN. THE RADIOACTIVITY IS THEN DETECTED OUTSIDE THE BODY BY USING SPECIAL CAMERAS AND A PICTURE CAN BE TAKEN. THIS WILL SHOW LOSS OF FUNCTIONAL DOPAMINERGIC NUERON TERMINALS IN THE STRATIUM OF PATIENTS WITH CLINICALLY UNCERTAIN PARKINSONS SYNDROMES. THE MATERIAL IS SUPPLIED IN GLASS VIAL SEALED WITH A RUBBER CLOSURE AND METAL OVERSEAL.

CLASSIFICATION IS DETERMINED ACCORDING TO GIRS 1 AND 6. CN 284440 30 FOR COMPOUNDS OF ARTIFICIAL RADIOACTIVE ISOTOPES. NOTE 1 (a) TO SECTION VI. NOTE 6 TO CHAPTER 28.